2220-7619

Russian Journal of Infection and Immunity

SPb RAACI

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1132 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1132 DOIs
2

Deposit reference lists for 323 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact323 DOIs
3

Add abstracts to 44 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact44 DOIs

DOIs for this ISSN

Showing the top 5 of 1435 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 ENTEROVIRUS INFECTION: VARIETY OF ETIOLOGICAL FACTORS AND CL… (10.15789/2220-7619-2014-1-27-36)
Abstract References ORCID License
77.82 5
2 DURATION OF POSTVACCINAL IMMUNITY AGAINST HEPATITIS B IN HEA… (10.15789/2220-7619-2015-1-89-92)
Abstract References ORCID License
69.90 4
3 CLINICAL SIGNIFICANCE OF SERUM LEVELS OF CYTOKINES AND TOTAL… (10.15789/2220-7619-2013-3-279-284)
Abstract References ORCID License
60.21 3
4 A single blind, placebo-controlled randomized study of the s… (10.15789/2220-7619-asb-1699)
ORCID
48.36 85
5 Neutrophil as a multifunctional relay in immune system (10.15789/2220-7619-2019-1-9-38)
ORCID
35.37 25
6 Methodology for assessing herd immunity to the SARS-CoV-2 vi… (10.15789/2220-7619-mfa-1770)
ORCID
35.37 25
7 THE NEW LOOK AT NEUTROPHILIC GRANULOCYTES: RETHINKING OLD DO… (10.15789/2220-7619-2017-3-219-230)
ORCID
34.51 23
8 INFLUENCE OF POPULATION IMMUNITY PECULIARITIES ON THE STRUCT… (10.15789/2220-7619-2018-3-341-348)
ORCID
34.04 22
9 METHODS OF ESTIMATION AND THE ROLE OF RESPIRATORY BURST IN T… (10.15789/2220-7619-2017-4-327-340)
ORCID
33.06 20
10 Climatic prerequisites for changing activity in the natural… (10.15789/2220-7619-2019-1-162-172)
ORCID
32.53 19
11 THE NEW LOOK AT NEUTROPHILIC GRANULOCYTES: RETHINKING OLD DO… (10.15789/2220-7619-2018-1-7-18)
ORCID
31.38 17
12 ANTIMICROBIAL PEPTIDES — A POTENTIAL REPLACEMENT FOR TRADITI… (10.15789/2220-7619-2018-3-295-308)
ORCID
30.76 16
13 Analysis of medical and social factors affecting the formati… (10.15789/2220-7619-2019-5-6-787-799)
ORCID
30.76 16
14 Predictive value of specific cytokines for lethal COVID-19 o… (10.15789/2220-7619-pvo-2043)
ORCID
29.40 14
15 SUSCEPTIBILITY TO ANTIBIOTICS IN KLEBSIELLA PNEUMONIAE STRAI… (10.15789/2220-7619-2018-1-79-84)
ORCID
27.85 12
16 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTION (10.15789/2220-7619-2018-2-139-149)
ORCID
27.85 12
17 The problem of pertussis in some regions of the world (10.15789/2220-7619-2019-2-354-362)
ORCID
27.85 12
18 Herd immunity to vaccine preventable infections in Saint Pet… (10.15789/2220-7619-hit-17797)
ORCID
27.85 12
19 Level of measles herd immunity assessed in hospital medical… (10.15789/2220-7619-lom-690)
ORCID
26.98 11
20 MOLECULAR CHARACTERIZATION OF MYCOBACTERIUM TUBERCULOSIS STR… (10.15789/2220-7619-2013-1-21-28)
ORCID
26.03 10
21 APOPTOSIS AND INFECTIOUS DISEASES (10.15789/2220-7619-2014-4-303-318)
ORCID
26.03 10
22 POPULATION IMMUNITY TO INFLUENZA VIRUS A(H1N1)pdm09, A(H3N2)… (10.15789/2220-7619-2017-1-27-33)
ORCID
26.03 10
23 THE PREVALENCE OF HIV RECOMBINANT FORMS IN RUSSIA AND COUNTR… (10.15789/2220-7619-2018-2-127-138)
ORCID
26.03 10
24 PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESC… (10.15789/2220-7619-2018-3-284-294)
ORCID
26.03 10
25 Comparison of the humoral and cellular immunity in COVID-19… (10.15789/2220-7619-cot-1809)
ORCID
26.03 10
26 Epidemiology and course of infectious diseases during the CO… (10.15789/2220-7619-eac-1958)
ORCID
26.03 10
27 Genomic analysis of <i>Klebsiella pneumoniae</i>… (10.15789/2220-7619-gao-15645)
ORCID
26.03 10
28 The COVID-19 pandemic: a systematic review of the current ev… (10.15789/2220-7619-tcp-1508)
ORCID
26.03 10
29 EPIDEMIOLOGICAL CHARACTERISTICS OF CHRONIC VIRAL HEPATITIS I… (10.15789/2220-7619-2011-3-255-262)
ORCID
25.00 9
30 INTERACTIONS OF PATHOGENIC BACTERIA WITH INNATE IMMUNE REACT… (10.15789/2220-7619-2012-3-581-596)
ORCID
25.00 9
31 STUDY OF THE DYNAMIC OF HELICOBACTER PYLORI INFECTION PREVAL… (10.15789/2220-7619-2012-4-741-746)
ORCID
25.00 9
32 PECULIARITIES OF SPECIFIC HUMORAL MESLES IMMUNE RESPONSE (10.15789/2220-7619-2013-3-243-250)
ORCID
25.00 9
33 HUMAN PARVOVIRUS В19: VIRUS CHARACTERISTICS, DISTRIBUTION AN… (10.15789/2220-7619-2013-4-311-322)
ORCID
25.00 9
34 ANTI-VIRAL ACTIVITY OF GLYCIRRHETINIC AND GLYCIRRHIZIC ACIDS (10.15789/2220-7619-2016-3-199-206)
ORCID
25.00 9
35 LIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS (10.15789/2220-7619-2017-2-107-116)
ORCID
25.00 9
36 MOLECULAR EPIDEMIOLOGY OF TUBERCULOSIS IN THE KALININGRAD RE… (10.15789/2220-7619-2017-4-367-374)
ORCID
25.00 9
37 MECHANISMS OF INTERRACTION OF HELICOBACTER PYLORI WITH EPITH… (10.15789/2220-7619-2018-3-273-283)
ORCID
25.00 9
38 Altered peripheral blood Th17 and follicular T-helper subset… (10.15789/2220-7619-2019-2-304-314)
ORCID
25.00 9
39 Maintaining immunological memory to the SARS-CoV-2 virus dur… (10.15789/2220-7619-mim-2009)
ORCID
25.00 9
40 Long-term monitoring of tick-borne viral encephalitis and ti… (10.15789/2220-7619-rol-1299)
ORCID
25.00 9
41 THE MODERN CONCEPTIONS ABOUT IMMUNOPATHOGENESIS OF INFECTION… (10.15789/2220-7619-2011-2-121-130)
ORCID
23.86 8
42 EPIDEMIOLOGICAL FEATURES OF HEPATITIS C VIRUS INFECTION IN T… (10.15789/2220-7619-2014-3-267-274)
ORCID
23.86 8
43 FEATURES OF THE IMMUNE RESPONSE DURING VIRAL INFECTION (10.15789/2220-7619-2015-2-148-156)
ORCID
23.86 8
44 MOLECULAR EPIDEMIOLOGY FEATURES OF HBV/HDV CO-INFECTION IN K… (10.15789/2220-7619-2016-2-141-150)
ORCID
23.86 8
45 ACUTE ENTERIC INFECTIONS POLYMERASE CHAIN REACTION ASSAY IN… (10.15789/2220-7619-2016-3-225-231)
ORCID
23.86 8
46 EFFECTIVENESS OF MOLECULAR-GENETIC DIAGNOSTICS DURING PERTUS… (10.15789/2220-7619-2017-2-162-170)
ORCID
23.86 8
47 PROTECTIVE ACTIVITY OF ASCORBIC ACID AT INFLUENZA INFECTION (10.15789/2220-7619-2017-4-319-326)
ORCID
23.86 8
48 FEATURES OF THE MICROBIOME OF THE UPPER RESPIRATORY TRACT IN… (10.15789/2220-7619-2017-4-341-349)
ORCID
23.86 8
49 CIRCULATION OF COXSACKIEVIRUS A IN HANDFOOT-MOUTH DISEASE IN… (10.15789/2220-7619-2018-4-3.35)
References ORCID
23.86 2
50 EVOLUTION OF THE VP1 REGION TYPE 2 VACCINE-DERIVED POLIOVIRU… (10.15789/2220-7619-2018-4-3.9)
References ORCID
23.86 2